Evidence map›Paper›PMID 38014947›Full record

ArticleJournal of virology2023

LORF9 of Marek's disease virus is involved in the early cytolytic replication of B lymphocytes and can act as a target for gene deletion vaccine development.

Xiaojing Zhu, Lele Wang, Lele Gong, Yunyun Zhai, Rui Wang, Jiaxin Jin, Wenlong Lu, Xuyang Zhao, Yifei Liao, Gaiping Zhang and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Xiaojing Zhu *College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.ORCID 0000-0003-4081-7245
Lele Wang *College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.
Lele GongCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.
Yunyun ZhaiCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.
Rui WangCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.
Jiaxin JinCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.
Wenlong LuCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.
Xuyang ZhaoCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.
Yifei LiaoDivision of Infectious Disease, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Gaiping ZhangCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.ORCID 0000-0002-3834-9975
Guoqing ZhuangCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.ORCID 0000-0002-9460-4379
Aijun SunCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.ORCID 0000-0003-0414-9489
Henan Agricultural University · CNBrigham and Women's Hospital · US

Funding

MOST | National Natural Science Foundation of China (NSFC) U21A20260
6 · The paper itself

Abstract

importanceMarek's disease virus (MDV) is a highly infectious and oncogenic virus that can induce severe T cell lymphomas in chickens. MDV encodes more than 100 genes, most of which have unknown functions. This work indicated that the

Indexed as

Herpesvirus 2, GallidMarek DiseaseMarek Disease VaccinesPoultry DiseasesAnimalsB-LymphocytesChickensGene DeletionVirus ReplicationMarek Disease Vaccinesgene deletionLORF9Marek’s diseaseMarek’s disease viruspathogenesis

Identifiers

PMID38014947
PMCPMC10734499
OpenAlexW4389084985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.